France · Funded startup
Funding summaryUpdated 26 Oct 2026
$97Mraised across 3 rounds since 2017, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Bpifrance
Earlybird Venture Capital
Wellington Partners
KurmaPartners
EQT Life Sciences
Andera PartnersSource recorded
PfizerLead
Idinvest PartnersWellington Partners
Alexandria Real Estate Equities
GimvKurmaPartners
Agent CapitalReported by FinSMEs
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
KurmaPartnersBoehringer Ingelheim Venture FundWellington PartnersPfizerLBpifrance throughLBpifranceEarlybird Venture CapitalIdinvest PartnersAlexandria Real Estate EquitiesGimvMissing a round, or an investor who was in one? Tell us.
This firm lists ImCheck Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
ImCheck Therapeutics's investors include KurmaPartners, Boehringer Ingelheim Venture Fund, Wellington Partners, Pfizer and Bpifrance through, and 11 more on record.
ImCheck Therapeutics has raised $97M across 3 rounds since 2017.
ImCheck Therapeutics's most recent round was a Grant of $22M in Aug 2024.
ImCheck Therapeutics's largest round on record is $53M (Series B), in Dec 2019, led by Pfizer.
ImCheck Therapeutics's first round on record, in May 2017, was backed by KurmaPartners, Boehringer Ingelheim Venture Fund and LSP and 1 others.
ImCheck Therapeutics's latest named round is a Grant, in Aug 2024.
ImCheck Therapeutics is based in France.
Pfizer led the Series B in 2019.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
France · 
